Literature DB >> 18778287

Expansion of CD4+ CD25+ Foxp3+ T cells by bone marrow-derived dendritic cells.

Ivo Marguti1, Guilherme Lopes Yamamoto, Thaís Boccia da Costa, Luiz Vicente Rizzo, Luciana Vieira de Moraes.   

Abstract

Dendritic cells (DCs) are the most important antigen-presenting cells of the immune system and have a crucial role in T-lymphocyte activation and adaptive immunity initiation. However, DCs have also been implicated in maintaining immunological tolerance. In this study, we evaluated changes in the CD4(+) CD25(+) Foxp3(+) T-cell population after co-culture of lymph node cells from BALB/c mice with syngeneic bone marrow-derived DCs. Our results showed an increase in CD4(+) CD25(+) Foxp3(+) T cells after co-culture which occurred regardless of the activation state of DCs and the presence of allogeneic apoptotic cells; however, it was greater when DCs were immature and were pulsed with the alloantigen. Interestingly, syngeneic apoptotic thymocytes were not as efficient as allogeneic apoptotic cells in expanding the CD4(+) CD25(+) Foxp3(+) T-cell population. In all experimental settings, DCs produced high amounts of transforming growth factor (TGF)-beta. The presence of allogeneic apoptotic cells induced interleukin (IL)-2 production in immature and mature DC cultures. This cytokine was also detected in the supernatants under all experimental conditions and enhanced when immature DCs were pulsed with the alloantigen. CD4(+) CD25(+) Foxp3(+) T-cell expansion during co-culture of lymph node cells with DCs strongly suggested that the presence of alloantigen enhanced the number of regulatory T cells (Tregs) in vitro. Our data also suggest a role for both TGF-beta and IL-2 in the augmentation of the CD4(+) CD25(+) Foxp3(+) population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18778287      PMCID: PMC2678181          DOI: 10.1111/j.1365-2567.2008.02927.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  40 in total

1.  A role for CD36 in the regulation of dendritic cell function.

Authors:  B C Urban; N Willcox; D J Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

2.  Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.

Authors:  M Itoh; T Takahashi; N Sakaguchi; Y Kuniyasu; J Shimizu; F Otsuka; S Sakaguchi
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

3.  CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion.

Authors:  Maria A Curotto de Lafaille; Andreia C Lino; Nino Kutchukhidze; Juan J Lafaille
Journal:  J Immunol       Date:  2004-12-15       Impact factor: 5.422

4.  Generation of antigen-specific, Foxp3-expressing CD4+ regulatory T cells by inhibition of APC proteosome function.

Authors:  Yingzi Cong; Astrid Konrad; Nuzhat Iqbal; Robin D Hatton; Casey T Weaver; Charles O Elson
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

5.  Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers.

Authors:  M C Bittencourt; S Perruche; E Contassot; S Fresnay; M H Baron; R Angonin; F Aubin; P Hervé; P Tiberghien; P Saas
Journal:  Blood       Date:  2001-07-01       Impact factor: 22.113

6.  Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells.

Authors:  K Steinbrink; H Jonuleit; G Müller; G Schuler; J Knop; A H Enk
Journal:  Blood       Date:  1999-03-01       Impact factor: 22.113

7.  Induction of tolerance by IL-10-treated dendritic cells.

Authors:  K Steinbrink; M Wölfl; H Jonuleit; J Knop; A H Enk
Journal:  J Immunol       Date:  1997-11-15       Impact factor: 5.422

8.  Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta.

Authors:  H Suzuki; T M Kündig; C Furlonger; A Wakeham; E Timms; T Matsuyama; R Schmits; J J Simard; P S Ohashi; H Griesser
Journal:  Science       Date:  1995-06-09       Impact factor: 47.728

9.  Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells.

Authors:  H Jonuleit; E Schmitt; G Schuler; J Knop; A H Enk
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

10.  Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells.

Authors:  K Inaba; S Turley; F Yamaide; T Iyoda; K Mahnke; M Inaba; M Pack; M Subklewe; B Sauter; D Sheff; M Albert; N Bhardwaj; I Mellman; R M Steinman
Journal:  J Exp Med       Date:  1998-12-07       Impact factor: 14.307

View more
  12 in total

1.  Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly.

Authors:  Anandharaman Veerapathran; Joseph Pidala; Francisca Beato; Xue-Zhong Yu; Claudio Anasetti
Journal:  Blood       Date:  2011-09-23       Impact factor: 22.113

2.  Immunosuppressive effect of renal cell carcinoma on phenotype and function of dendritic cells.

Authors:  Lichen Teng; Yongsheng Chen; Dexin Ding; Hongshuang Dai; Guobin Liu; Changfu Li
Journal:  Int Urol Nephrol       Date:  2013-11-08       Impact factor: 2.370

3.  Effect of bone marrow-derived CD11b(+)F4/80 (+) immature dendritic cells on the balance between pro-inflammatory and anti-inflammatory cytokines in DBA/1 mice with collagen-induced arthritis.

Authors:  Jingjing Fu; Lingling Zhang; Shanshan Song; Kangliang Sheng; Ying Li; Peipei Li; Shasha Song; Qingtong Wang; Jianhong Chu; Wei Wei
Journal:  Inflamm Res       Date:  2014-01-24       Impact factor: 4.575

4.  Allogeneic apoptotic thymocyte-stimulated dendritic cells expand functional regulatory T cells.

Authors:  Thaís Boccia da Costa; Luiz R Sardinha; Rafael Larocca; Jean P S Peron; Luiz V Rizzo
Journal:  Immunology       Date:  2011-03-01       Impact factor: 7.397

5.  Serum amyloid A induces mitogenic signals in regulatory T cells via monocyte activation.

Authors:  Khoa D Nguyen; Claudia Macaubas; Phi Truong; Nan Wang; Tieying Hou; Taejin Yoon; Elizabeth D Mellins
Journal:  Mol Immunol       Date:  2014-03-13       Impact factor: 4.407

6.  T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent manner.

Authors:  Yoichiro Uchida; Bibo Ke; Maria Cecilia S Freitas; Hideo Yagita; Hisaya Akiba; Ronald W Busuttil; Nader Najafian; Jerzy W Kupiec-Weglinski
Journal:  Gastroenterology       Date:  2010-07-13       Impact factor: 22.682

7.  The emerging role of T cell immunoglobulin mucin-1 in the mechanism of liver ischemia and reperfusion injury in the mouse.

Authors:  Yoichiro Uchida; Bibo Ke; Maria Cecilia S Freitas; Haofeng Ji; Danyun Zhao; Elizabeth R Benjamin; Nader Najafian; Hideo Yagita; Hisaya Akiba; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

8.  Murine myeloid dendritic cells that phagocytose apoptotic T cells inhibit the immune response via NO.

Authors:  Kaili Zhong; Wengang Song; Qian Wang; Chao Wang; Xi Liu; Dongwei Chen; Zhongli Zhu; Yiqing Wu; Weijing Zhang; Minghui Zhang
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

9.  Dll4-Notch signaling in Flt3-independent dendritic cell development and autoimmunity in mice.

Authors:  Fabienne Billiard; Camille Lobry; Guillaume Darrasse-Jèze; Janelle Waite; Xia Liu; Hugo Mouquet; Amanda DaNave; Michelle Tait; Juliana Idoyaga; Marylène Leboeuf; Christos A Kyratsous; Jacquelynn Burton; Julie Kalter; Apostolos Klinakis; Wen Zhang; Gavin Thurston; Miriam Merad; Ralph M Steinman; Andrew J Murphy; George D Yancopoulos; Iannis Aifantis; Dimitris Skokos
Journal:  J Exp Med       Date:  2012-04-30       Impact factor: 14.307

10.  Dendritic cells control CD4+CD25+ Treg cell suppressor function in vitro through juxtacrine delivery of IL-2.

Authors:  Katarina Kulhankova; Todd Rouse; Mohamed E Nasr; Elizabeth H Field
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.